Certified by Founder Lodge
LifeArc Ventures
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $16,000,000
7 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
LifeArc Ventures invests in early-stage science-led companies that can benefit from our advice, scientific insight and venture funding.
We’re committed to encouraging and financing innovativ
| Company | Date | Round | Raised |
|---|---|---|---|
Maxion Therapeutics |
February, 21 ,2023 | Series A | $16,000,000 |
Ozlo Sleep |
August, 07 ,2023 | Series A | $10,000,000 |
Fluid Biomed Inc. |
December, 18 ,2024 | Series A | $27,000,000 |
Tribune Therapeutics |
March, 27 ,2025 | Seed | $39,883,965 |
Hillstar Bio |
April, 02 ,2025 | Series A | Undisclosed Amount |
EXCIVA GmbH |
January, 20 ,2026 | Series B | $59,817,135 |
Cytospire Therapeutics Ltd |
May, 07 ,2026 | Series A | $82,984,705 |
Maxion Therapeutics
Ozlo Sleep
Fluid Biomed Inc.
Tribune Therapeutics
Hillstar Bio
EXCIVA GmbH
Cytospire Therapeutics Ltd
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Neurosoft Bioelectronics | $7,500,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
CVRD Health | $5,000,000 | (May 22, 2026)
Oorja Bio | $30,000,000 | (May 22, 2026)
Findd.AI | $21,000,000 | (May 22, 2026)